The use of membrane translocating peptides to identify sites of interaction between the C5a receptor and downstream effector proteins

Immunology

Volumn 112, Issue 4, 2004, Pages 590-596

  Auger, Graham A ^a   Smith, Brenda M ^a   Pease, James E ^b   Barker, Michael D ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Complement: complement receptor, C5a; Receptors: G protein coupled receptor, complement receptor, domains (intracellular); Signalling: G proteins, receptors

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CONTROLLED STUDY; DNA SEQUENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR DOWN REGULATION;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; GLUTATHIONE TRANSFERASE; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, G-PROTEIN-COUPLED; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; TRANSLOCATION, GENETIC;

EID: 4043128086     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01919.x     Document Type: Article

References (22)

1. Snyderman R, Uhing RJ. Chemoattractant stimulus-response coupling. In: Gallin JI, Goldstein IM, eds. Inflammation: Basic Principles and Clinical Correlates 2nd edn. New York: Raven Press Ltd., 1992:421-39.
2. Homey B, Zlotnik A. Chemokines in allergy. Curr Opin Immunol 1999; 11:626-34.
3. Clapham DE, Neer EJ. G protein beta gamma subunits. Annu Rev Pharmacol Toxicol 1997; 37:167-203.
4. Hamm HE. The many faces of G protein signaling. J Biol Chem 1998; 273:669-72.
5. Bokoch GM. Chemoattractant signaling and leukocyte activation. Blood 1995; 86:1649-60.
6. Keane MP, Strieter RM. Chemokine signaling in inflammation. Crit Care Med 2000; 28:N13-26.
7. Palczewski K, Kumasaka T, Hori T, et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 2000; 289:739-45.
8. Gerber BO, Meng EC, Dotsch V, Baranski TJ, Bourne HR. An activation switch in the ligand binding pocket of the C5a receptor. J Biol Chem 2001; 276:3394-400.
9. Farzan M, Schnitzler CE, Vasilieva N, Leung D, Kuhn J, Gerard C, Gerard NP, Choe H. Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor. J Exp Med 2001; 193:1059-66.
10. Baranski TJ, Herzmark P, Lichtarge O, et al. C5a receptor activation. Genetic identification of critical residues in four transmembrane helices. J Biol Chem 1999; 274:15757-65.
11. Geva A, Lassere TB, Lichtarge O, Pollitt SK, Baranski TJ. Genetic mapping of the human C5a receptor. Identification of transmembrane amino acids critical for receptor function. J Biol Chem 2000; 275:35393-401.
12. Bock D, Martin U, Gartner S, et al. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization. Eur J Immunol 1997; 27:1522-9.
13. Naik N, Giannini E, Brouchon L, Boulay F. Internalization and recycling of the C5a anaphylatoxin receptor. Evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain. J Cell Sci 1997; 110:2381-90.
14. Delli Bovi P, Curatola AM, Kern FG, Greco A, Ittmann M. Basilico C. An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell 1987; 50:729-37.
15. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 1995; 270:14255-8.
16. Rojas M, Donahue JP, Tan Z, Lin YZ. Genetic engineering of proteins with cell membrane permeability. Nat Biotechnol 1998; 16:370-5.
17. Monk PN, Pease JE, Barker MD. C5a stimulus-secretion coupling in rat basophilic leukemia (RBL-2H3) cells transfected with the human C5a receptor is mediated by pertussis and cholera toxin-sensitive G-proteins. Biochem Mol Biol Int 1994; 32:13-20.
18. Rojas M, Yao S, Lin YZ. Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J Biol Chem 1996; 271:27456-61.
19. Turkson J, Ryan D, Kim JS, et al. Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem 2001; 276:45443-55.
20. Schreiber RE, Prossnitz ER, Ye RD, Cochrane CG, Bokoch GM. Domains of the human neutrophil N-formyl peptide receptor involved in G-protein coupling - mapping with receptor-derived peptides. J Biol Chem 1994; 269:326-31.
21. Christophe T, Rabiet MJ, Tardif M, Milcent MD, Boulay F. Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells. J Biol Chem 2000; 275:1656-64.
22. Bennett TA, Maestas DC, Prossnitz ER. Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved 'DRY' sequence. J Biol Chem 2000; 275:24590-4.